Vanderbilt University - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Size: px
Start display at page:

Download "Vanderbilt University - Pharmaceuticals & Healthcare - Deals and Alliances Profile"

Transcription

1 Vanderbilt University - Pharmaceuticals & Healthcare - Deals and Alliances Profile

2 Vanderbilt University - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sector Publishing Intelligence Limited (SPi) has been marketing business and market research reports from selected publishers for over five years. SPi offers a personal service to our customers with dedicated research managers who will work with you to source the best report for your needs. Based in the UK, SPi is well positioned to coordinate our customers' orders sourced from over 30 global report publishers. We are pleased to present details of this report to assist your buying decision and administrative process. You will find easy-to-use How To Buy information on the last page of this document. We look forward to being of service to you. If you have bulk and/or recurring requirements, please get in touch - we can liaise with publishers to obtain sample pages and negotiate discounts on your behalf. Phone: +44 (0) or 2

3 Vanderbilt University - Pharmaceuticals & Healthcare - Deals and Alliances Profile Summary Vanderbilt University (Vanderbilt) is a medical and research university that provides professional degrees. The university offers graduate and undergraduate degrees in the fields of engineering, music, liberal arts and sciences, education and human development. It provides services such as clinical research and research support services. Vanderbilt s research support services includes study organization, IRB navigation, training, protocol development, preparation of study related documents, funding and contractual agreements and overall program advisory. The university offers its services through blair school of music, divinity school, school of engineering, law school, graduate school, school of medicine, and others. Vanderbilt is headquartered in Nashville, Tennessee, the US. Vanderbilt University - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions. GlobalData derived the data presented in this report from proprietary in-house Pharma etrack deals database, and primary and secondary research. Scope - Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. - Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector. - Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company s (major public companies) key financial metrics and ratios. - Business Description - A brief description of the company's operations. - Key Employees - A list of the key executives of the company. - Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company. - Key Competitors - A list of the key competitors of the company. - Key Recent Developments - A brief on recent news about the company. Reasons to Buy 3

4 Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements - The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period. Understand the company's business segments' expansion / divestiture strategy - The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy. Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios. Equip yourself with detailed information about the company s operations to identify potential customers and suppliers. - The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors. Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events. Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs. Note*: Some sections may be missing if data is unavailable for the company. Additional Details Publisher : Global Data Reference : GDPH63465D Number of Pages : 39 Report Format : PDF Publisher Information : A leading global business intelligence provider offering advanced analytics to help clients make better, more informed decisions every day. 4

5 Table Of Contents for Vanderbilt University - Pharmaceuticals & Healthcare - Deals and Alliances Profile Table of Contents Table of Contents 2 List of Tables 3 List of Figures 4 Vanderbilt University, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD Vanderbilt University, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD Vanderbilt University, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD Vanderbilt University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD Vanderbilt University, Medical Devices Deals, 2010 to YTD Vanderbilt University, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD Vanderbilt University, Pharmaceuticals & Healthcare, Deal Details 12 Partnerships 12 Illumina Enters into Agreement with Vanderbilt University 12 Diatherix Labs Enters into Research Agreement with Vanderbilt University Medical Center 13 MedImmune, GlaxoSmithKline and Vanderbilt University Enter into Agreement 14 BioReference Labs Enters into Co-Development Agreement with Vanderbilt-Ingram 15 Incyte Enters into Research Agreement with Vanderbilt University Medical Center 16 Vanderbilt University Enters Into Research Agreement With GlaxoSmithKline For Obesity Drug 17 Baptist Memorial Health Care Enters Into Research Agreement With Vanderbilt University 19 Vanderbilt University Enters Into Agreement With Bristol-Myers Squibb To Develop Drugs For Parkinson s Disease 20 Scripps Research Enters Into Joint Venture Agreement With Vanderbilt University 22 Seaside Therapeutics Enters Into Research Collaboration With Vanderbilt University 24 Licensing Agreements 25 La Jolla Pharma Enters into Licensing Agreement with Vanderbilt University 25 AstraZeneca Enters into Licensing Agreement with Vanderbilt University 26 AstraZeneca Enters Into Licensing Agreement With Vanderbilt University For Neuroscience Drug Discovery 27 Parker Hannifin Enters Into Licensing Agreement With Vanderbilt University For Exoskeleton Technology 28 Nanoferix Enters into Licensing Agreement with Vanderbilt University Center for Technology Transfer and Commercialization 30 Vanderbilt University Enters Into Licensing Agreement With Karuna Pharma 31 Asset Transactions 32 Cumberland Pharma Acquires Rights Of Ifetroban From Vanderbilt University 32 Acquisition 34 Vanderbilt University Sells Microarrays 34 Vanderbilt University - Key Competitors 35 Key Employees 36 Locations And Subsidiaries 37 Head Office 37 Other Locations & Subsidiaries 37 Appendix 39 Methodology 39 5

6 About GlobalData 39 Contact Us 39 Disclaimer 39 6

7 List Of Tables in Vanderbilt University - Pharmaceuticals & Healthcare - Deals and Alliances Profile List of Tables Vanderbilt University, Pharmaceuticals & Healthcare, Key Facts, Vanderbilt University, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD Vanderbilt University, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD Vanderbilt University, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD Vanderbilt University, Deals By Therapy Area, 2010 to YTD Vanderbilt University, Medical Devices Deals, 2010 to YTD Vanderbilt University, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD Illumina Enters into Agreement with Vanderbilt University 12 Diatherix Labs Enters into Research Agreement with Vanderbilt University Medical Center 13 MedImmune, GlaxoSmithKline and Vanderbilt University Enter into Agreement 14 BioReference Labs Enters into Co-Development Agreement with Vanderbilt-Ingram 15 Incyte Enters into Research Agreement with Vanderbilt University Medical Center 16 Vanderbilt University Enters Into Research Agreement With GlaxoSmithKline For Obesity Drug 17 Baptist Memorial Health Care Enters Into Research Agreement With Vanderbilt University 19 Vanderbilt University Enters Into Agreement With Bristol-Myers Squibb To Develop Drugs For Parkinson s Disease 20 Scripps Research Enters Into Joint Venture Agreement With Vanderbilt University 22 Seaside Therapeutics Enters Into Research Collaboration With Vanderbilt University 24 La Jolla Pharma Enters into Licensing Agreement with Vanderbilt University 25 AstraZeneca Enters into Licensing Agreement with Vanderbilt University 26 AstraZeneca Enters Into Licensing Agreement With Vanderbilt University For Neuroscience Drug Discovery 27 Parker Hannifin Enters Into Licensing Agreement With Vanderbilt University For Exoskeleton Technology 28 Nanoferix Enters into Licensing Agreement with Vanderbilt University Center for Technology Transfer and Commercialization 30 Vanderbilt University Enters Into Licensing Agreement With Karuna Pharma 31 Cumberland Pharma Acquires Rights Of Ifetroban From Vanderbilt University 32 Vanderbilt University Sells Microarrays 34 Vanderbilt University, Key Competitors 35 Vanderbilt University, Key Employees 36 Vanderbilt University, Subsidiaries 37 7

8 List Of Figures, Charts and Diagrams in Vanderbilt University - Pharmaceuticals & Healthcare - Deals and Alliances Profile List of Figures Vanderbilt University, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD Vanderbilt University, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD Vanderbilt University, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD Vanderbilt University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD Vanderbilt University, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD Vanderbilt University, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD Vanderbilt University, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD Vanderbilt University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD Vanderbilt University, Medical Devices Deals, 2010 to YTD

9 How to Buy... Vanderbilt University - Pharmaceuticals & Healthcare - Deals and Alliances Profile Option 1 - Online Go to our website and pay online with any major debit or credit card: Option 2 - Request a Proforma Invoice Fill in the details below, and either Scan this page and it to us at or Fax it to us at +44 (0) We will send you a Proforma Invoice and deliver your report on settlement. Your Name: Job Title: Your Your Contact Phone: Company Name: Address: Post/Zip Code: Country: P.O. Number: Any Other Instructions: Pricing Options: (please tick one) $250 Single User Price $500 Site License Price $750 Global License Price Payment Options: (please tick one) Online Credit Card (we will you the invoice with a payment link) Direct Wire Transfer (we will you the invoice with our bank details) Authorising Signature: Option 3 - Phone Us on +44 (0) We will be delighted to give you our personal attention. 9

Nektar Therapeutics (NKTR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Nektar Therapeutics (NKTR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Nektar Therapeutics (NKTR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Nektar Therapeutics (NKTR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing

More information

Acadia Pharmaceuticals Inc. (ACAD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Acadia Pharmaceuticals Inc. (ACAD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Acadia Pharmaceuticals Inc. (ACAD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Acadia Pharmaceuticals Inc. (ACAD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio

More information

ConvaTec Group Plc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

ConvaTec Group Plc - Pharmaceuticals & Healthcare - Deals and Alliances Profile ConvaTec Group Plc - Pharmaceuticals & Healthcare - Deals and Alliances Profile ConvaTec Group Plc - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing business

More information

Bionure Farma SL - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Bionure Farma SL - Pharmaceuticals & Healthcare - Deals and Alliances Profile Bionure Farma SL - Pharmaceuticals & Healthcare - Deals and Alliances Profile Bionure Farma SL - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing business and

More information

Starpharma Holdings Limited (SPL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Starpharma Holdings Limited (SPL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Starpharma Holdings Limited (SPL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Starpharma Holdings Limited (SPL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio

More information

Collegium Pharmaceutical Inc (COLL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Collegium Pharmaceutical Inc (COLL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Collegium Pharmaceutical Inc (COLL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Collegium Pharmaceutical Inc (COLL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile The Business

More information

Glenmark Pharmaceuticals Inc., USA - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Glenmark Pharmaceuticals Inc., USA - Pharmaceuticals & Healthcare - Deals and Alliances Profile Glenmark Pharmaceuticals Inc., USA - Pharmaceuticals & Healthcare - Deals and Alliances Profile Glenmark Pharmaceuticals Inc., USA - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio

More information

Natera, Inc. (NTRA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Natera, Inc. (NTRA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Natera, Inc. (NTRA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Natera, Inc. (NTRA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing business

More information

DNA2.0 Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

DNA2.0 Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile DNA2.0 Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile DNA2.0 Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing business and market research

More information

Emcure Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Emcure Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile Emcure Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile Emcure Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing

More information

Median Kliniken GmbH & Co. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Median Kliniken GmbH & Co. - Pharmaceuticals & Healthcare - Deals and Alliances Profile Median Kliniken GmbH & Co. - Pharmaceuticals & Healthcare - Deals and Alliances Profile Median Kliniken GmbH & Co. - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing

More information

North China Pharmaceutical Group Corp. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

North China Pharmaceutical Group Corp. - Pharmaceuticals & Healthcare - Deals and Alliances Profile North China Pharmaceutical Group Corp. - Pharmaceuticals & Healthcare - Deals and Alliances Profile North China Pharmaceutical Group Corp. - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio

More information

Starpharma Holdings Limited (SPL) - Medical Equipment - Deals and Alliances Profile

Starpharma Holdings Limited (SPL) - Medical Equipment - Deals and Alliances Profile Starpharma Holdings Limited (SPL) - Medical Equipment - Deals and Alliances Profile Starpharma Holdings Limited (SPL) - Medical Equipment - Deals and Alliances Profile BioPortfolio has been marketing business

More information

Karo Pharma AB (KARO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Karo Pharma AB (KARO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Karo Pharma AB (KARO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Karo Pharma AB (KARO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing business

More information

DaVita HealthCare Partners Inc. (DVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

DaVita HealthCare Partners Inc. (DVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile DaVita HealthCare Partners Inc. (DVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile DaVita HealthCare Partners Inc. (DVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sector

More information

Bessemer Venture Partners - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Bessemer Venture Partners - Pharmaceuticals & Healthcare - Deals and Alliances Profile Bessemer Venture Partners - Pharmaceuticals & Healthcare - Deals and Alliances Profile Bessemer Venture Partners - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing

More information

Paramount Mining Corporation Limited (PCP) - Metals and Mining - Deals and Alliances Profile

Paramount Mining Corporation Limited (PCP) - Metals and Mining - Deals and Alliances Profile Paramount Mining Corporation Limited (PCP) - Metals and Mining - Deals and Alliances Profile Paramount Mining Corporation Limited (PCP) - Metals and Mining - Deals and Alliances Profile Sector Publishing

More information

Pharmaxis Ltd (PXS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Pharmaxis Ltd (PXS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Pharmaxis Ltd (PXS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Pharmaxis Ltd (PXS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing business

More information

Mesa Laboratories, Inc. (MLAB) - Medical Equipment - Deals and Alliances Profile

Mesa Laboratories, Inc. (MLAB) - Medical Equipment - Deals and Alliances Profile Mesa Laboratories, Inc. (MLAB) - Medical Equipment - Deals and Alliances Profile Mesa Laboratories, Inc. (MLAB) - Medical Equipment - Deals and Alliances Profile BioPortfolio has been marketing business

More information

Faes Farma SA (FAE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Faes Farma SA (FAE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Faes Farma SA (FAE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Faes Farma SA (FAE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing business

More information

Bioton SA (BIO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Bioton SA (BIO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Bioton SA (BIO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Bioton SA (BIO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing business and market

More information

Mesa Laboratories, Inc. (MLAB) - Medical Equipment - Deals and Alliances Profile

Mesa Laboratories, Inc. (MLAB) - Medical Equipment - Deals and Alliances Profile Mesa Laboratories, Inc. (MLAB) - Medical Equipment - Deals and Alliances Profile Mesa Laboratories, Inc. (MLAB) - Medical Equipment - Deals and Alliances Profile BioPortfolio has been marketing business

More information

Becton, Dickinson and Company (BDX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Becton, Dickinson and Company (BDX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Becton, Dickinson and Company (BDX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Becton, Dickinson and Company (BDX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio

More information

Mindray Medical International Limited (MR) - Medical Equipment - Deals and Alliances Profile

Mindray Medical International Limited (MR) - Medical Equipment - Deals and Alliances Profile Mindray Medical International Limited (MR) - Medical Equipment - Deals and Alliances Profile Mindray Medical International Limited (MR) - Medical Equipment - Deals and Alliances Profile BioPortfolio has

More information

The Walt Disney Company - Strategy, SWOT and Corporate Finance Report

The Walt Disney Company - Strategy, SWOT and Corporate Finance Report The Walt Disney Company - Strategy, SWOT and Corporate Finance Report The Walt Disney Company - Strategy, SWOT and Corporate Finance Report The Business Research Store is run by Sector Publishing Intelligence

More information

Gap, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Gap, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Gap, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Gap, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Sector Publishing Intelligence

More information

McCain Foods Limited, Inc. - Strategic SWOT Analysis Review

McCain Foods Limited, Inc. - Strategic SWOT Analysis Review McCain Foods Limited, Inc. - Strategic SWOT Analysis Review McCain Foods Limited, Inc. - Strategic SWOT Analysis Review Sector Publishing Intelligence Limited (SPi) has been marketing business and market

More information

Kohler Co. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Kohler Co. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Kohler Co. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Kohler Co. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Sector Publishing Intelligence

More information

Vorwerk and Co. KG - Strategy, SWOT and Corporate Finance Report

Vorwerk and Co. KG - Strategy, SWOT and Corporate Finance Report Vorwerk and Co. KG - Strategy, SWOT and Corporate Finance Report Vorwerk and Co. KG - Strategy, SWOT and Corporate Finance Report The Business Research Store is run by Sector Publishing Intelligence Ltd.

More information

Maruti Suzuki India Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Maruti Suzuki India Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Maruti Suzuki India Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Maruti Suzuki India Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment

More information

Phone: +44 (0) or BioPortfolio Limited

Phone: +44 (0) or   BioPortfolio Limited Global Laser Holographic Display Market by Product (Medical Scanners, Digital Signage, Kiosk, Notebook), by Application (Medical, Commercial, Industrial, Defense, Consumer Electronics), by Geography -

More information

Surgical Sutures Market By Product Type [Automated Suturing Devices (Disposable Automated Suturing Devices, And Re-Usable Automated Suturing

Surgical Sutures Market By Product Type [Automated Suturing Devices (Disposable Automated Suturing Devices, And Re-Usable Automated Suturing Surgical Sutures Market By Product Type [Automated Suturing Devices (Disposable Automated Suturing Devices, And Re-Usable Automated Suturing Devices), and Sutures (Sutures by Type (Absorbable & Non-Absorbable),

More information

Compression Therapy - Medical Devices Pipeline Assessment, 2017

Compression Therapy - Medical Devices Pipeline Assessment, 2017 Compression Therapy - Medical Devices Pipeline Assessment, 2017 Compression Therapy - Medical Devices Pipeline Assessment, 2017 BioPortfolio has been marketing business and market research reports from

More information

Critical Limb Ischemia - Pipeline Review, H1 2017

Critical Limb Ischemia - Pipeline Review, H1 2017 Critical Limb Ischemia - Pipeline Review, H1 2017 Critical Limb Ischemia - Pipeline Review, H1 2017 BioPortfolio has been marketing business and market research reports from selected publishers for over

More information

Generics Series: Authorized Generics Analysis Stemming the Generics Tide

Generics Series: Authorized Generics Analysis Stemming the Generics Tide Generics Series: Authorized Generics Analysis Stemming the Generics Tide Report summary An overview of the authorized generics landscape, including drivers and resistors for both branded and generics players

More information

PwC Deals $42B. Global Pharma & Life Sciences Deals Insights Q Update

PwC Deals $42B. Global Pharma & Life Sciences Deals Insights Q Update PwC Deals Q3 16 Update Executive summary Global Pharma and Life Sciences (PLS) deal activity declined both in volume and value this quarter compared to the prior quarter and Q3 15. The considerable decrease

More information

Johnson & Johnson (JNJ) - Medical Equipment - Deals and Alliances Profile

Johnson & Johnson (JNJ) - Medical Equipment - Deals and Alliances Profile Johnson & Johnson (JNJ) - Medical Equipment - Deals and Alliances Profile Johnson & Johnson (JNJ) - Medical Equipment - Deals and Alliances Profile BioPortfolio has been marketing business and market research

More information

Digital Health Funding and M&A

Digital Health Funding and M&A Digital Health Funding and M&A 2018 Third Quarter and Nine Month Report Funding and Merger & Acquisition activity for the Digital Health sector http://www.mercomcapital.com 1 Copyright 2010-2016 Mercom

More information

WOLPERT ASSOCIATES, INC. Strategic Advisory Services Firm Overview

WOLPERT ASSOCIATES, INC. Strategic Advisory Services Firm Overview Strategic Advisory Services 2018 Firm Overview Our Foundational Principles Strategic Advice for Biopharmaceutical, Medical Technology and Life Science sectors A Focus on Strategic Thinking in the Context

More information

State of Licensing 2011 Update

State of Licensing 2011 Update State of Licensing 2011 Update Moderators/Speakers Hemmie Chang, Chair, Licensing & Strategic Alliance Practice Group, Foley Hoag LLP Ranya Dajani, Executive Director, Strategic Transactions Group, Bristol-

More information

Roche's Global IP Strategy 10th. JIPA IP Symposium, Tokyo Dr. Axel Braun F. Hoffmann La Roche Ltd.

Roche's Global IP Strategy 10th. JIPA IP Symposium, Tokyo Dr. Axel Braun F. Hoffmann La Roche Ltd. Roche's Global IP Strategy 10th. JIPA IP Symposium, Tokyo 2011 Dr. Axel Braun F. Hoffmann La Roche Ltd. Content Roche Company Profile The IP Department Patent Filings Global Strategy Sales Overview IP

More information

1 Table of Contents 1.1 List of Tables 1.2 List of Figures 2 Introduction 3 Global Neurostimulation Devices Market - An Overview 3.

1 Table of Contents 1.1 List of Tables 1.2 List of Figures 2 Introduction 3 Global Neurostimulation Devices Market - An Overview 3. 1 Table of Contents 1.1 List of Tables 1.2 List of Figures 2 Introduction 3 Global Neurostimulation Devices Market - An Overview 3.1 Spinal Cord Stimulator 3.2 Deep Brain Stimulator 3.3 Vagus Nerve Stimulator

More information

Purvi B. Maniar Member of the Firm

Purvi B. Maniar Member of the Firm Purvi B. Maniar Member of the Firm New York 250 Park Avenue New York, New York 10177 Tel: 212-351-3757 Fax: 212-878-8600 St. Louis Tel: 314-395-2775 pmaniar@ebglaw.com PURVI B. MANIAR is a Member of the

More information

New York Bar admission (or eligibility to obtain admission promptly) is required.

New York Bar admission (or eligibility to obtain admission promptly) is required. Job Opportunities To apply to any of the positions send cover letter referencing job opening with resume and salary requirements to info@bryantrabbino.com Senior Level Corporate Finance Attorney We are

More information

direct Assistant: Jeanne Tomazin

direct Assistant: Jeanne Tomazin BRIAN R. BROWDER Partner, Immediate Past Chair, Healthcare Department 615.850.8636 direct brian.browder@wallerlaw.com Assistant: Jeanne Tomazin 615.850.8557 jeanne.tomazin@wallerlaw.com Nashville City

More information

Bayer Inc. Science for a Better Life. Talking with Phil Blake, President, Bayer Inc., HealthCare Representative and Head, Pharmaceuticals Division

Bayer Inc. Science for a Better Life. Talking with Phil Blake, President, Bayer Inc., HealthCare Representative and Head, Pharmaceuticals Division Bayer Inc. Science for a Better Life Talking with Phil Blake, President, Bayer Inc., HealthCare Representative and Head, Pharmaceuticals Division Please review your career path to date, leading to your

More information

Data-Driven Evaluation: The Key to Developing Successful Pharma Partnerships

Data-Driven Evaluation: The Key to Developing Successful Pharma Partnerships R&D Solutions for PHARMA & LIFE SCIENCES DRUG DISCOVERY & DEVELOPMENT Data-Driven Evaluation: The Key to Developing Successful Pharma Partnerships Summary For pharmaceutical companies to succeed, it is

More information

Perspectives of Innovative Small Companies on the Industry s Prospects for 2012 and Beyond

Perspectives of Innovative Small Companies on the Industry s Prospects for 2012 and Beyond Perspectives of Innovative Small Companies on the Industry s Prospects for 2012 and Beyond ACI Forum on Structuring, Negotiating and Managing Life Sciences Collaborations and Acquisitions February 28,

More information

Fall State of the Industry Report UF SID MARTIN FLORIDA BIODATABASE

Fall State of the Industry Report UF SID MARTIN FLORIDA BIODATABASE Fall 2015 State of the Industry Report UF SID MARTIN FLORIDA BIODATABASE Industry Overview The expansion of Florida s biotech industry remains resilient with an overall growth rate of 92% in the number

More information

Dealdoc. Acquisition agreement for Gambro. Baxter International Gambro. Dec , Wildwood Ventures Ltd. All rights reserved.

Dealdoc. Acquisition agreement for Gambro. Baxter International Gambro. Dec , Wildwood Ventures Ltd. All rights reserved. Dealdoc Acquisition agreement for Gambro Baxter International Gambro Dec 04 2012 Acquisition agreement for Gambro Companies: Baxter International Gambro Announcement date: Dec 04 2012 Deal value, US$m:

More information

April By Type of Approach- Transfemoral and Transapical. By Region- North America, Europe, APAC and RoW

April By Type of Approach- Transfemoral and Transapical. By Region- North America, Europe, APAC and RoW Global Transcatheter Aortic Valve Replacement (TAVR) Market: Analysis By Type of Approach (Transfemoral and Transapical), By Region, By Country: Opportunities and Forecast (2017-2022) By Type of Approach-

More information

Reinventing Invention: Advancing Collaboration for Sustainable Bioscience R&D

Reinventing Invention: Advancing Collaboration for Sustainable Bioscience R&D Reinventing Invention: Advancing Collaboration for Sustainable Bioscience R&D John C. Lechleiter, Ph.D. Chairman, President, and Chief Executive Officer Eli Lilly and Company Washington Biotechnology &

More information

Chartwell Introduction and AEC Capabilities

Chartwell Introduction and AEC Capabilities Chartwell Introduction and AEC Capabilities Comprehensive Financial Advisory Experience Chartwell provides financial advisory solutions to the middle market; areas of expertise include corporate finance,

More information

Intellectual property governance and strategic value creation:

Intellectual property governance and strategic value creation: Intellectual property governance and strategic value creation: some evidence from European organizations in, pharmaceutical and public research fields Dr. Federica Rossi (rossi.federica@unito.it) Universita

More information

Scripps Florida. Accelerating Discoveries, Saving Lives. Presentation to the Urban Land Institute November 4, 2011

Scripps Florida. Accelerating Discoveries, Saving Lives. Presentation to the Urban Land Institute November 4, 2011 Scripps Florida Accelerating Discoveries, Saving Lives Presentation to the Urban Land Institute November 4, 2011 Alex Bruner Associate Vice President, Philanthropy 1921- Founding of the Scripps Metabolic

More information

GLOBAL RISK AND INVESTIGATIONS JAPAN CAPABILITY STATEMENT

GLOBAL RISK AND INVESTIGATIONS JAPAN CAPABILITY STATEMENT GLOBAL RISK AND INVESTIGATIONS JAPAN CAPABILITY STATEMENT CRITICAL THINKING AT THE CRITICAL TIME ABOUT US The Global Risk and Investigations Practice (GRIP) of FTI Consulting is the leading provider of

More information

JOHN JACK R. TUPMAN, JR CURRICULUM VITAE

JOHN JACK R. TUPMAN, JR CURRICULUM VITAE JOHN JACK R. TUPMAN, JR CURRICULUM VITAE September 2018 John R. Tupman, Jr. is a consultant focused on business development and licensing in the life sciences industry. He is currently working as a consultant

More information

Pharma - Biotech Collaborations: Optimizing Success, Minimizing Risk and Maintaining Alignment

Pharma - Biotech Collaborations: Optimizing Success, Minimizing Risk and Maintaining Alignment Presenter: Randall Sunberg Morgan Lewis May 16, 2008 In cooper Biography Randall Sunberg partner Morgan Lewis, Princeton Phone: 609.919.6606 Randall B. Sunberg is a partner in Morgan Lewis's Business and

More information

Curriculum Vita. Paul H. Keckley, Ph.D. Career Focus: Expert on health system transformation. Career History: Current:

Curriculum Vita. Paul H. Keckley, Ph.D. Career Focus: Expert on health system transformation. Career History: Current: Curriculum Vita Paul H. Keckley, Ph.D. Career Focus: Expert on health system transformation Career History: Current: Managing Editor, The Keckley Report (2006-present) The Keckley Report is a weekly blog

More information

Clare Capital. Credentials

Clare Capital. Credentials Clare Capital Credentials About Us Clare Capital undertakes rigorous analysis and provides thoughtful advice from extensive experience to help Boards and CEOs make optimal capital, asset and strategic

More information

Venture Capital Report

Venture Capital Report Venture Capital Report China 2 Q 2018 The following report presents Dow Jones VentureSource s quarterly findings for Chinese venture capital fundraising, investment, valuation, and liquidity. The included

More information

United States Sterilization Equipment Market Outlook to 2021

United States Sterilization Equipment Market Outlook to 2021 United States Sterilization Equipment Market Outlook to 2021 United States Sterilization Equipment Market Outlook to 2021 BioPortfolio has been marketing business and market research reports from selected

More information

Q&A with Samira Salman

Q&A with Samira Salman APRIL 2017 VOL. 5 ISSUE 122 R E P O R T Q&A with Samira Salman Founder of Salman Solutions. Principle Series: Family Office Insights sits down with Samira Salman to discuss successful deal structuring

More information

Venture Capital Report

Venture Capital Report Venture Capital Report Europe 1Q 2018 The following report presents Dow Jones VentureSource s quarterly findings for European venture capital fundraising, investment, valuation, and liquidity. The included

More information

Your Content Your Way

Your Content Your Way MY VIEW Your Content Your Way My View allows you to view only the topics you want to follow. Choose from a list of available topics, which are individualized for each publications, and design your own

More information

Healthcare and Life Sciences

Healthcare and Life Sciences Healthcare and Life Sciences Introduction Uría Menéndez is an independent law firm that was founded in Madrid in 1946 by Professor Rodrigo Uría González. We currently have seventeen offices in Spain, Portugal,

More information

Indoor Positioning and Navigation System Market Research Report- Forecast 2023

Indoor Positioning and Navigation System Market Research Report- Forecast 2023 Report Information More information from: https://www.marketresearchfuture.com/reports/1775 Indoor Positioning and Navigation System Market Research Report- Forecast 2023 Report / Search Code: MRFR/SEM/1243-CRR

More information

Local Production of Pharmaceuticals and Related Technology Transfer UNCTAD/CD-TFT 1. Background

Local Production of Pharmaceuticals and Related Technology Transfer UNCTAD/CD-TFT 1. Background Local Production of Pharmaceuticals and Related Technology Transfer Dr. Padmashree Gehl Sampath Division for Technology and Logistics UNCTAD UNCTAD/CD-TFT 1 1 Background Case studies part of the EU funded

More information

Cherry AB. Investing in a broad gaming portfolio. CEO Anders Holmgren GP Bullhound 6 December 2017

Cherry AB. Investing in a broad gaming portfolio. CEO Anders Holmgren GP Bullhound 6 December 2017 Cherry AB Investing in a broad gaming portfolio CEO Anders Holmgren GP Bullhound 6 December 2017 The game is on Cherry is investing in a broad portfolio of online gaming companies Cherry s strategy is

More information

gellerbiopharm A healthcare investment banking division of Financial West Group, member FINRA/SIPC. Office (212) Web gellerbp.

gellerbiopharm A healthcare investment banking division of Financial West Group, member FINRA/SIPC. Office (212) Web gellerbp. gellerbiopharm A healthcare investment banking division of Financial West Group, member FINRA/SIPC. Office (212) 315-0600 Web gellerbp.com Summary Personal Diverse, world-class team of top biotech bankers,

More information

PROTECT Project. Joanna Groves Chief Executive Officer 27 April 2010 EFPIA Patient Think-Tank Brussels, Belgium

PROTECT Project. Joanna Groves Chief Executive Officer 27 April 2010 EFPIA Patient Think-Tank Brussels, Belgium PROTECT Project Joanna Groves Chief Executive Officer 27 April 2010 EFPIA Patient Think-Tank Brussels, Belgium Content of Presentation About IAPO Overview of PROTECT Work Package 4 - New methods for data

More information

GLOBAL MARKETS AND TECHNOLOGIES FOR ADVANCED DRUG DELIVERY SYSTEMS

GLOBAL MARKETS AND TECHNOLOGIES FOR ADVANCED DRUG DELIVERY SYSTEMS GLOBAL MARKETS AND TECHNOLOGIES FOR ADVANCED DRUG DELIVERY SYSTEMS PHM006K March 2016 Himani Singhi Wadhwa Project Analyst ISBN: 1-62296-254-0 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481

More information

THE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (EASTERN-EUROPE EDITION)

THE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (EASTERN-EUROPE EDITION) THE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (EASTERN-EUROPE EDITION) Feedback from 93 Eastern-European patient groups PUBLISHED JULY 2016 CONTENTS ABOUT THIS REPORT Page 1 WHAT DID

More information

How attractive is the BioRegion of Catalonia for foreign investment? Guy Nohra Co-Founder and Managing Director of Alta Partners

How attractive is the BioRegion of Catalonia for foreign investment? Guy Nohra Co-Founder and Managing Director of Alta Partners How attractive is the BioRegion of Catalonia for foreign investment? Guy Nohra Co-Founder and Managing Director of Alta Partners How attractive is the BioRegion of Catalonia for foreign investment? M ost

More information

Robert A. Greising Partner

Robert A. Greising Partner Robert A. Greising Partner P: (317) 238-6215 F: (317) 636-1507 E: rgreising@kdlegal.com Indianapolis Office One Indiana Square Suite 2800 Indianapolis, IN 46204-2079 Robert Greising is a Partner in the

More information

Where the brightest scientific minds thrive. IMED Early Talent and Post Doc programmes

Where the brightest scientific minds thrive. IMED Early Talent and Post Doc programmes Where the brightest scientific minds thrive. IMED Early Talent and Post Doc programmes Scientific innovation is at the heart of everything we do. Scientific innovation is at the heart of our business and

More information

Venture Capital Report

Venture Capital Report Venture Capital Report Europe 3Q 2015 The following report presents Dow Jones VentureSource s quarterly findings for European venture capital fundraising, investment, valuation, and liquidity. The included

More information

NOT FOR DISTRIBUTION IN THE USA,CANADA, JAPAN OR AUSTRALIA

NOT FOR DISTRIBUTION IN THE USA,CANADA, JAPAN OR AUSTRALIA Press release Baar, 28 January 2008 Attractive portfolio of investments in biotech and medical technology to be opened to the public HBM BioVentures announces further information of its planned IPO on

More information

Publication Date Reporter Pharma Boardroom 24/05/2018 Staff Reporter

Publication Date Reporter Pharma Boardroom 24/05/2018 Staff Reporter Publication Date Reporter Pharma Boardroom 24/05/2018 Staff Reporter Pharma Boardroom An Exclusive Interview with Jonathan Hunt CEO, Syngene International, India. Jonathan Hunt, CEO of Syngene International,

More information

The role of Intellectual Property (IP) in R&D-based companies: Setting the context of the relative importance and Management of IP

The role of Intellectual Property (IP) in R&D-based companies: Setting the context of the relative importance and Management of IP The role of Intellectual Property (IP) in R&D-based companies: Setting the context of the relative importance and Management of IP Thomas Gering Ph.D. Technology Transfer & Scientific Co-operation Joint

More information

Transaction Services. Member of Invest Europe and SECA Swiss Priva te E quity & Corporate Finance Association

Transaction Services. Member of Invest Europe and SECA Swiss Priva te E quity & Corporate Finance Association Transaction Services Profile BridgeLink M&A und Corporate Finance BridgeLink is an international service company providing comprehensive solutions in M&A and Corporate Finance. We are located in Basel

More information

Robert A. Greising Partner

Robert A. Greising Partner Robert A. Greising Partner P: (317) 238-6215 F: (317) 636-1507 E: rgreising@kdlegal.com Indianapolis Office One Indiana Square Suite 2800 Indianapolis, IN 46204-2079 Robert Greising serves as a Partner

More information

Global Paper Stationery Market Research Report 2016

Global Paper Stationery Market Research Report 2016 Published on Market Research Reports Inc. (https://www.marketresearchreports.com) Home > Global Paper Stationery Market Research Report 2016 Global Paper Stationery Market Research Report 2016 Publication

More information

Overview of Health Technology Assessment (HTA) from Asia Pacific Perspective

Overview of Health Technology Assessment (HTA) from Asia Pacific Perspective Overview of Health Technology Assessment (HTA) from Asia Pacific Perspective Hong Li, PhD., MPH Group Director, Bristol-Myers Squibb Adjunct Associate Professor University of Cincinnati, USA; and DUKE-NUS

More information

Military Robotics - Emerging Trends and Future Outlook. Reference code: DF4580PR Published: July 2015 Single user price: US$1950

Military Robotics - Emerging Trends and Future Outlook. Reference code: DF4580PR Published: July 2015 Single user price: US$1950 Military Robotics - Emerging Trends and Future Outlook Reference code: DF4580PR Published: July 2015 Single user price: US$1950 1 Summary Military Robotics - Emerging Trends and Future Outlook is a report

More information

Digital Health AI in Life Sciences

Digital Health AI in Life Sciences Digital Health AI in Life Sciences Surging Digital Health AI Fundraising Drives Transformation in Life Sciences DECEMBER Digital Health AI Accelerates Innovation in Life Science Industry Artificial intelligence

More information

Mara H. Rogers, Partner Norton Rose Fulbright

Mara H. Rogers, Partner Norton Rose Fulbright Mara H. Rogers Partner Norton Rose Fulbright US LLP New York T:+1 212 318 3206 F:+1 212 318 3400 mara.rogers@nortonrosefulbright.com vcard (+Outlook) Related services Corporate, M&A and securities Mergers

More information

We would be delighted to discuss your needs and how we could support you, so please get in touch. Our contact details appear on the final page.

We would be delighted to discuss your needs and how we could support you, so please get in touch. Our contact details appear on the final page. Fluent in Fintech Whether you are developing, procuring, or investing in financial technology we understand the opportunities and challenges your business can face and we are keen to support ambitious

More information

Global DAW Software Market Research Report 2016

Global DAW Software Market Research Report 2016 Published on Market Research Reports Inc. (https://www.marketresearchreports.com) Home > Global DAW Software Market Research Report 2016 Global DAW Software Market Research Report 2016 Publication ID:

More information

January Bob DeSutter Managing Director Co-Head of Health Care

January Bob DeSutter Managing Director Co-Head of Health Care January 2007 Dear Friends and Clients, For much of our 112 year history, serving innovative health care companies has been an important part of our mission at Piper Jaffray. Our goal is to be lead advisor

More information

Security and Risk Assessment in GDPR: from policy to implementation

Security and Risk Assessment in GDPR: from policy to implementation Global Data Privacy Security and Risk Assessment in GDPR: from policy to implementation Enisa Workshop Roma - February 8, 2018 Nicola Orlandi Head of Data Privacy Pharma Nicola Orlandi Nicola Orlandi is

More information

Wineus AG. Company presentation 2016

Wineus AG. Company presentation 2016 Wineus AG Company presentation 2016 Wineus Entrepreneurial Finance Your success is our success Our customers Entrepreneurs Investors Public and private companies Our services Investment advisory Mergers

More information

Top 50 Emerging Technologies & Growth Opportunities

Top 50 Emerging Technologies & Growth Opportunities Top 50 Emerging Technologies & Growth Opportunities Multi-billion Dollar Technologies Ready to Energize Industries and Transform our World THE VALUE PROPOSITION TechVision s annual Top 50 Emerging Technologies

More information

World Offshore Wind Market Forecast Prospects, Technologies, World Markets

World Offshore Wind Market Forecast Prospects, Technologies, World Markets 2016 World Offshore Wind Market Forecast 2016-2025 Prospects, Technologies, World Markets Contents Table of Contents 1 Summary and Conclusions...7 Summary... 8 Conclusions... 9 2 Drivers and Indicators...

More information

The 9 Sources of Innovation: Which to Use?

The 9 Sources of Innovation: Which to Use? The 9 Sources of Innovation: Which to Use? By Kevin Closson, Nerac Analyst Innovation is a topic fraught with controversy and conflicting viewpoints. Is innovation slowing? Is it as strong as ever? Is

More information

SMES AND GLOBAL GROWTH: FINDING LOCAL PARTNERS

SMES AND GLOBAL GROWTH: FINDING LOCAL PARTNERS SMES AND GLOBAL GROWTH: FINDING LOCAL PARTNERS SMEs venturing into new countries find a wide range of partnership forms between the two extremes of formal joint ventures and go-it-alone subsidiaries. Hoping

More information

Cannabis Practice Group

Cannabis Practice Group Cannabis Practice Group McMillan LLP Vancouver Calgary Toronto Ottawa Montréal Hong Kong Cannabis mcmillan.ca Practice Group 1 Medical cannabis is booming and McMillan is at the forefront of developments

More information

I Overview. II Hallmarks of Turnpoint Group. III Corporate Financial Services. IV Assignments. V Clients. VI Market Segments

I Overview. II Hallmarks of Turnpoint Group. III Corporate Financial Services. IV Assignments. V Clients. VI Market Segments Content I Overview II Hallmarks of Turnpoint Group III Corporate Financial Services IV Assignments V Clients VI Market Segments VII Selection of transactions a. advising the seller b. advising the buyer

More information

Speaker/Panelist Profiles

Speaker/Panelist Profiles Speaker/Panelist Profiles Mr. Kenji Toda Chairperson, International Affairs Committee Japan Pharmaceutical manufacturers Association (JPMA) Senior Vice President, Government Relations

More information

MassMEDIC Annual Meeting

MassMEDIC Annual Meeting MassMEDIC Annual Meeting Sector and Massachusetts EvaluateMedTech Analysis Tom Sommer, President MassMedic Celebrating 20 years Founded in 1996 350+ member companies Played a key role in the FDA Modernization

More information